...
首页> 外文期刊>Leukemia and lymphoma >Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.
【24h】

Multicenter study of comparative outcomes of hematopoietic stem cell transplant for peripheral T cell lymphoma and natural killer/T-cell lymphoma.

机译:外周血T细胞淋巴瘤和自然杀伤/ T细胞淋巴瘤造血干细胞移植比较结果的多中心研究。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Prior studies have suggested high-dose chemotherapy followed by stem cell rescue as a plausible upfront treatment option for patients with peripheral T cell lymphoma (PTCL) and natural killer/T-cell (NK/T) lymphoma in order to improve the currently dismal prognosis [1-3]. Although several clinical trials have been performed which support the role of autologous [1-7] as well as allogeneic hematopoietic stem cell transplant (HSCT) [8,9], there is still a paucity of data on the role HSCT for these diseases. We present here a report of HSCT for adults with PTCL and NK/T lymphomas in a multicenter study to determine the effectiveness of HSCT in patients with various PTCL subtypes as well as NK/T lymphoma.
机译:先前的研究表明,大剂量化学疗法后进行干细胞抢救是外周T细胞淋巴瘤(PTCL)和自然杀伤/ T细胞(NK / T)淋巴瘤患者的合理的前期治疗选择,以改善目前的预后不良[1-3]。尽管已经进行了一些支持自体[1-7]以及同种异体造血干细胞移植(HSCT)[8,9]的作用的临床试验,但是关于这些疾病的HSCT的作用仍然缺乏数据。我们在这里提供一项多中心研究中针对成人PTCL和NK / T淋巴瘤的HSCT的报告,以确定HSCT在各种PTCL亚型以及NK / T淋巴瘤患者中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号